235 related articles for article (PubMed ID: 27295191)
1. Tumour endothelial cells in high metastatic tumours promote metastasis via epigenetic dysregulation of biglycan.
Maishi N; Ohba Y; Akiyama K; Ohga N; Hamada J; Nagao-Kitamoto H; Alam MT; Yamamoto K; Kawamoto T; Inoue N; Taketomi A; Shindoh M; Hida Y; Hida K
Sci Rep; 2016 Jun; 6():28039. PubMed ID: 27295191
[TBL] [Abstract][Full Text] [Related]
2. Biglycan is a specific marker and an autocrine angiogenic factor of tumour endothelial cells.
Yamamoto K; Ohga N; Hida Y; Maishi N; Kawamoto T; Kitayama K; Akiyama K; Osawa T; Kondoh M; Matsuda K; Onodera Y; Fujie M; Kaga K; Hirano S; Shinohara N; Shindoh M; Hida K
Br J Cancer; 2012 Mar; 106(6):1214-23. PubMed ID: 22374465
[TBL] [Abstract][Full Text] [Related]
3. Tumor endothelial cells accelerate tumor metastasis.
Maishi N; Hida K
Cancer Sci; 2017 Oct; 108(10):1921-1926. PubMed ID: 28763139
[TBL] [Abstract][Full Text] [Related]
4. Novel antiangiogenic therapy targeting biglycan using tumor endothelial cell-specific liposomal siRNA delivery system.
Maishi N; Sakurai Y; Hatakeyama H; Umeyama Y; Nakamura T; Endo R; Alam MT; Li C; Annan DA; Kikuchi H; Morimoto H; Morimoto M; Akiyama K; Ohga N; Hida Y; Harashima H; Hida K
Cancer Sci; 2022 May; 113(5):1855-1867. PubMed ID: 35266253
[TBL] [Abstract][Full Text] [Related]
5. Identification of tumor endothelial cells with high aldehyde dehydrogenase activity and a highly angiogenic phenotype.
Ohmura-Kakutani H; Akiyama K; Maishi N; Ohga N; Hida Y; Kawamoto T; Iida J; Shindoh M; Tsuchiya K; Shinohara N; Hida K
PLoS One; 2014; 9(12):e113910. PubMed ID: 25437864
[TBL] [Abstract][Full Text] [Related]
6. ROS enhance angiogenic properties via regulation of NRF2 in tumor endothelial cells.
Hojo T; Maishi N; Towfik AM; Akiyama K; Ohga N; Shindoh M; Hida Y; Minowa K; Fujisawa T; Hida K
Oncotarget; 2017 Jul; 8(28):45484-45495. PubMed ID: 28525375
[TBL] [Abstract][Full Text] [Related]
7. Lysyl oxidase secreted by tumour endothelial cells promotes angiogenesis and metastasis.
Osawa T; Ohga N; Akiyama K; Hida Y; Kitayama K; Kawamoto T; Yamamoto K; Maishi N; Kondoh M; Onodera Y; Fujie M; Shinohara N; Nonomura K; Shindoh M; Hida K
Br J Cancer; 2013 Oct; 109(8):2237-47. PubMed ID: 24045659
[TBL] [Abstract][Full Text] [Related]
8. Tumour endothelial cells acquire drug resistance in a tumour microenvironment.
Hida K; Akiyama K; Ohga N; Maishi N; Hida Y
J Biochem; 2013 Mar; 153(3):243-9. PubMed ID: 23293323
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of tumor endothelial cells: comparison between tumor endothelial cells isolated from high- and low-metastatic tumors.
Ohga N; Ishikawa S; Maishi N; Akiyama K; Hida Y; Kawamoto T; Sadamoto Y; Osawa T; Yamamoto K; Kondoh M; Ohmura H; Shinohara N; Nonomura K; Shindoh M; Hida K
Am J Pathol; 2012 Mar; 180(3):1294-1307. PubMed ID: 22245217
[TBL] [Abstract][Full Text] [Related]
10. Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis.
Hiratsuka S; Watanabe A; Aburatani H; Maru Y
Nat Cell Biol; 2006 Dec; 8(12):1369-75. PubMed ID: 17128264
[TBL] [Abstract][Full Text] [Related]
11. Identification of gene function and functional pathways by systemic plasmid-based ribozyme targeting in adult mice.
Kashani-Sabet M; Liu Y; Fong S; Desprez PY; Liu S; Tu G; Nosrati M; Handumrongkul C; Liggitt D; Thor AD; Debs RJ
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3878-83. PubMed ID: 11891271
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of multidrug transporter in tumor endothelial cells enhances antiangiogenic effects of low-dose metronomic paclitaxel.
Akiyama K; Maishi N; Ohga N; Hida Y; Ohba Y; Alam MT; Kawamoto T; Ohmura H; Yamada K; Torii C; Shindoh M; Hida K
Am J Pathol; 2015 Feb; 185(2):572-80. PubMed ID: 25498238
[TBL] [Abstract][Full Text] [Related]
13. H3K27 Demethylase JMJD3 Employs the NF-κB and BMP Signaling Pathways to Modulate the Tumor Microenvironment and Promote Melanoma Progression and Metastasis.
Park WY; Hong BJ; Lee J; Choi C; Kim MY
Cancer Res; 2016 Jan; 76(1):161-70. PubMed ID: 26729791
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic regulation in human melanoma: past and future.
Sarkar D; Leung EY; Baguley BC; Finlay GJ; Askarian-Amiri ME
Epigenetics; 2015; 10(2):103-21. PubMed ID: 25587943
[TBL] [Abstract][Full Text] [Related]
15. Biglycan expression in the melanoma microenvironment promotes invasiveness via increased tissue stiffness inducing integrin-β1 expression.
Andrlová H; Mastroianni J; Madl J; Kern JS; Melchinger W; Dierbach H; Wernet F; Follo M; Technau-Hafsi K; Has C; Rao Mittapalli V; Idzko M; Herr R; Brummer T; Ungefroren H; Busch H; Boerries M; Narr A; Ihorst G; Vennin C; Schmitt-Graeff A; Minguet S; Timpson P; Duyster J; Meiss F; Römer W; Zeiser R
Oncotarget; 2017 Jun; 8(26):42901-42916. PubMed ID: 28476030
[TBL] [Abstract][Full Text] [Related]
16. DDR2 inhibition reduces migration and invasion of murine metastatic melanoma cells by suppressing MMP2/9 expression through ERK/NF-κB pathway.
Poudel B; Lee YM; Kim DK
Acta Biochim Biophys Sin (Shanghai); 2015 Apr; 47(4):292-8. PubMed ID: 25733533
[TBL] [Abstract][Full Text] [Related]
17. RASSF6 exhibits promoter hypermethylation in metastatic melanoma and inhibits invasion in melanoma cells.
Mezzanotte JJ; Hill V; Schmidt ML; Shinawi T; Tommasi S; Krex D; Schackert G; Pfeifer GP; Latif F; Clark GJ
Epigenetics; 2014 Nov; 9(11):1496-503. PubMed ID: 25482183
[TBL] [Abstract][Full Text] [Related]
18. Ataxia-telangiectasia mutated activation mediates tumor necrosis factor-alpha induced MMP-13 up-regulation and metastasis in lung cancer cells.
Yan HQ; Zhang D; Shi YY; You X; Shi L; Li Q; Gao FG
Oncotarget; 2016 Sep; 7(38):62070-62083. PubMed ID: 27556690
[TBL] [Abstract][Full Text] [Related]
19. Paired box 5 is a frequently methylated lung cancer tumour suppressor gene interfering β-catenin signalling and GADD45G expression.
Zhao L; Li S; Gan L; Li C; Qiu Z; Feng Y; Li J; Li L; Li C; Peng W; Xu C; Wang Z; Hui T; Ren G; Tao Q; Xiang T
J Cell Mol Med; 2016 May; 20(5):842-54. PubMed ID: 26843424
[TBL] [Abstract][Full Text] [Related]
20. IRX1 hypomethylation promotes osteosarcoma metastasis via induction of CXCL14/NF-κB signaling.
Lu J; Song G; Tang Q; Zou C; Han F; Zhao Z; Yong B; Yin J; Xu H; Xie X; Kang T; Lam Y; Yang H; Shen J; Wang J
J Clin Invest; 2015 May; 125(5):1839-56. PubMed ID: 25822025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
